Contacts, documents and full notice history are available with a subscription.
Justification 1 notice 2 documents

6505--Pharmacy Amtagvi 36C24826N0268

Solicitation 36C24826N0268 Copied Notice ID ddc858d391e44a289af609f1c3b2e4c5 Copied VETERANS AFFAIRS, DEPARTMENT OF — 248-NETWORK CONTRACT OFFICE 8 (36C248)
SAM.gov
Posted
Jan 05, 2026
Deadline
No deadline
Set-aside
None
NAICS
325412
PSC
6505

Summary

AI-generated · Jan 06, 2026

Limited-sources justification documents a sole-source procurement under the Federal Supply Schedule to acquire Amtagvi from IOVANCE BIOTHERAPEUTICS MANUFACTURING LLC. The action awards $393,365.83 for this item.

See attached Limited Sources Justification for the Federal Supply Schedule Order 36F79724D0206 36C24826N0268.

From Justification posted on Jan 05, 2026

Notice history

1
  1. Justification LATEST Posted Jan 05, 2026 View

Details

Solicitation number 36C24826N0268
Notice ID ddc858d391e44a289af609f1c3b2e4c5
Award number 36F79724D0206
Notice type Justification
Product / Service (PSC) 6505
NAICS 325412
Archive date Mar 06, 2026

Award Information

Awardee
1
Total Awarded
$393,365.83
Award Date
Jan 05, 2026

Awardees

Company Name UEI CAGE Code Location
IOVANCE BIOTHERAPEUTICS MANUFACTURING LLC ZPQBE4ARVWL3 N/A PHILADELPHIA

Contacts

primary
Cindy Smith

Contracting Officer

Email

Phone

Agency

VETERANS AFFAIRS, DEPARTMENT OF
VETERANS AFFAIRS, DEPARTMENT OF
248-NETWORK CONTRACT OFFICE 8 (36C248)

Place of Performance

Dates

Posted Jan 05, 2026 7 months ago
Last Updated Aug 06, 2026 1 day ago
Awarded Jan 05, 2026 7 months ago